Back to Course

2025 PACUPrep BCCCP Preparatory Course

0% Complete
0/0 Steps
  1. Pulmonary

    ARDS
    4 Topics
    |
    1 Quiz
  2. Asthma Exacerbation
    4 Topics
    |
    1 Quiz
  3. COPD Exacerbation
    4 Topics
    |
    1 Quiz
  4. Cystic Fibrosis
    6 Topics
    |
    1 Quiz
  5. Drug-Induced Pulmonary Diseases
    3 Topics
    |
    1 Quiz
  6. Mechanical Ventilation Pharmacotherapy
    5 Topics
    |
    1 Quiz
  7. Pleural Disorders
    5 Topics
    |
    1 Quiz
  8. Pulmonary Hypertension (Acute and Chronic severe pulmonary hypertension)
    5 Topics
    |
    1 Quiz
  9. Cardiology
    Acute Coronary Syndromes
    6 Topics
    |
    1 Quiz
  10. Atrial Fibrillation and Flutter
    6 Topics
    |
    1 Quiz
  11. Cardiogenic Shock
    4 Topics
    |
    1 Quiz
  12. Heart Failure
    7 Topics
    |
    1 Quiz
  13. Hypertensive Crises
    5 Topics
    |
    1 Quiz
  14. Ventricular Arrhythmias and Sudden Cardiac Death Prevention
    5 Topics
    |
    1 Quiz
  15. NEPHROLOGY
    Acute Kidney Injury (AKI)
    5 Topics
    |
    1 Quiz
  16. Contrast‐Induced Nephropathy
    5 Topics
    |
    1 Quiz
  17. Drug‐Induced Kidney Diseases
    5 Topics
    |
    1 Quiz
  18. Rhabdomyolysis
    5 Topics
    |
    1 Quiz
  19. Syndrome of Inappropriate Antidiuretic Hormone (SIADH)
    5 Topics
    |
    1 Quiz
  20. Renal Replacement Therapies (RRT)
    5 Topics
    |
    1 Quiz
  21. Neurology
    Status Epilepticus
    5 Topics
    |
    1 Quiz
  22. Acute Ischemic Stroke
    5 Topics
    |
    1 Quiz
  23. Subarachnoid Hemorrhage
    5 Topics
    |
    1 Quiz
  24. Spontaneous Intracerebral Hemorrhage
    5 Topics
    |
    1 Quiz
  25. Neuromonitoring Techniques
    5 Topics
    |
    1 Quiz
  26. Gastroenterology
    Acute Upper Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  27. Acute Lower Gastrointestinal Bleeding
    5 Topics
    |
    1 Quiz
  28. Acute Pancreatitis
    5 Topics
    |
    1 Quiz
  29. Enterocutaneous and Enteroatmospheric Fistulas
    5 Topics
    |
    1 Quiz
  30. Ileus and Acute Intestinal Pseudo-obstruction
    5 Topics
    |
    1 Quiz
  31. Abdominal Compartment Syndrome
    5 Topics
    |
    1 Quiz
  32. Hepatology
    Acute Liver Failure
    5 Topics
    |
    1 Quiz
  33. Portal Hypertension & Variceal Hemorrhage
    5 Topics
    |
    1 Quiz
  34. Hepatic Encephalopathy
    5 Topics
    |
    1 Quiz
  35. Ascites & Spontaneous Bacterial Peritonitis
    5 Topics
    |
    1 Quiz
  36. Hepatorenal Syndrome
    5 Topics
    |
    1 Quiz
  37. Drug-Induced Liver Injury
    5 Topics
    |
    1 Quiz
  38. Dermatology
    Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
    5 Topics
    |
    1 Quiz
  39. Erythema multiforme
    5 Topics
    |
    1 Quiz
  40. Drug Reaction (or Rash) with Eosinophilia and Systemic Symptoms (DRESS)
    5 Topics
    |
    1 Quiz
  41. Immunology
    Transplant Immunology & Acute Rejection
    5 Topics
    |
    1 Quiz
  42. Solid Organ & Hematopoietic Transplant Pharmacotherapy
    5 Topics
    |
    1 Quiz
  43. Graft-Versus-Host Disease (GVHD)
    5 Topics
    |
    1 Quiz
  44. Hypersensitivity Reactions & Desensitization
    5 Topics
    |
    1 Quiz
  45. Biologic Immunotherapies & Cytokine Release Syndrome
    5 Topics
    |
    1 Quiz
  46. Endocrinology
    Relative Adrenal Insufficiency and Stress-Dose Steroid Therapy
    5 Topics
    |
    1 Quiz
  47. Hyperglycemic Crisis (DKA & HHS)
    5 Topics
    |
    1 Quiz
  48. Glycemic Control in the ICU
    5 Topics
    |
    1 Quiz
  49. Thyroid Emergencies: Thyroid Storm & Myxedema Coma
    5 Topics
    |
    1 Quiz
  50. Hematology
    Acute Venous Thromboembolism
    5 Topics
    |
    1 Quiz
  51. Drug-Induced Thrombocytopenia
    5 Topics
    |
    1 Quiz
  52. Anemia of Critical Illness
    5 Topics
    |
    1 Quiz
  53. Drug-Induced Hematologic Disorders
    5 Topics
    |
    1 Quiz
  54. Sickle Cell Crisis in the ICU
    5 Topics
    |
    1 Quiz
  55. Methemoglobinemia & Dyshemoglobinemias
    5 Topics
    |
    1 Quiz
  56. Toxicology
    Toxidrome Recognition and Initial Management
    5 Topics
    |
    1 Quiz
  57. Management of Acute Overdoses – Non-Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  58. Management of Acute Overdoses – Cardiovascular Agents
    5 Topics
    |
    1 Quiz
  59. Toxic Alcohols and Small-Molecule Poisons
    5 Topics
    |
    1 Quiz
  60. Antidotes and Gastrointestinal Decontamination
    5 Topics
    |
    1 Quiz
  61. Extracorporeal Removal Techniques
    5 Topics
    |
    1 Quiz
  62. Withdrawal Syndromes in the ICU
    5 Topics
    |
    1 Quiz
  63. Infectious Diseases
    Sepsis and Septic Shock
    5 Topics
    |
    1 Quiz
  64. Pneumonia (CAP, HAP, VAP)
    5 Topics
    |
    1 Quiz
  65. Endocarditis
    5 Topics
    |
    1 Quiz
  66. CNS Infections
    5 Topics
    |
    1 Quiz
  67. Complicated Intra-abdominal Infections
    5 Topics
    |
    1 Quiz
  68. Antibiotic Stewardship & PK/PD
    5 Topics
    |
    1 Quiz
  69. Clostridioides difficile Infection
    5 Topics
    |
    1 Quiz
  70. Febrile Neutropenia & Immunocompromised Hosts
    5 Topics
    |
    1 Quiz
  71. Skin & Soft-Tissue Infections / Acute Osteomyelitis
    5 Topics
    |
    1 Quiz
  72. Urinary Tract and Catheter-related Infections
    5 Topics
    |
    1 Quiz
  73. Pandemic & Emerging Viral Infections
    5 Topics
    |
    1 Quiz
  74. Supportive Care (Pain, Agitation, Delirium, Immobility, Sleep)
    Pain Assessment and Analgesic Management
    5 Topics
    |
    1 Quiz
  75. Sedation and Agitation Management
    5 Topics
    |
    1 Quiz
  76. Delirium Prevention and Treatment
    5 Topics
    |
    1 Quiz
  77. Sleep Disturbance Management
    5 Topics
    |
    1 Quiz
  78. Immobility and Early Mobilization
    5 Topics
    |
    1 Quiz
  79. Oncologic Emergencies
    5 Topics
    |
    1 Quiz
  80. End-of-Life Care & Palliative Care
    Goals of Care & Advance Care Planning
    5 Topics
    |
    1 Quiz
  81. Pain Management & Opioid Therapy
    5 Topics
    |
    1 Quiz
  82. Dyspnea & Respiratory Symptom Management
    5 Topics
    |
    1 Quiz
  83. Sedation & Palliative Sedation
    5 Topics
    |
    1 Quiz
  84. Delirium Agitation & Anxiety
    5 Topics
    |
    1 Quiz
  85. Nausea, Vomiting & Gastrointestinal Symptoms
    5 Topics
    |
    1 Quiz
  86. Management of Secretions (Death Rattle)
    5 Topics
    |
    1 Quiz
  87. Fluids, Electrolytes, and Nutrition Management
    Intravenous Fluid Therapy and Resuscitation
    5 Topics
    |
    1 Quiz
  88. Acid–Base Disorders
    5 Topics
    |
    1 Quiz
  89. Sodium Homeostasis and Dysnatremias
    5 Topics
    |
    1 Quiz
  90. Potassium Disorders
    5 Topics
    |
    1 Quiz
  91. Calcium and Magnesium Abnormalities
    5 Topics
    |
    1 Quiz
  92. Phosphate and Trace Electrolyte Management
    5 Topics
    |
    1 Quiz
  93. Enteral Nutrition Support
    5 Topics
    |
    1 Quiz
  94. Parenteral Nutrition Support
    5 Topics
    |
    1 Quiz
  95. Refeeding Syndrome and Specialized Nutrition
    5 Topics
    |
    1 Quiz
  96. Trauma and Burns
    Initial Resuscitation and Fluid Management in Trauma
    5 Topics
    |
    1 Quiz
  97. Hemorrhagic Shock, Massive Transfusion, and Trauma‐Induced Coagulopathy
    5 Topics
    |
    1 Quiz
  98. Burns Pharmacotherapy
    5 Topics
    |
    1 Quiz
  99. Burn Wound Care
    5 Topics
    |
    1 Quiz
  100. Open Fracture Antibiotics
    5 Topics
    |
    1 Quiz

Participants 432

  • Allison Clemens
  • April
  • ababaabhay
  • achoi2392
  • adhoward1
Show more
Lesson 13, Topic 1
In Progress

Foundational Principles of Hypertensive Crises

Lesson Progress
0% Complete
Foundations of Hypertensive Crises

Foundations of Hypertensive Crises: Epidemiology, Pathophysiology, and Risk Factors

Learning Objectives Icon A checkmark inside a circle, symbolizing achieved learning goals.

Learning Objective

Describe foundational principles of hypertensive crises, including definitions, epidemiology, pathophysiology, risk factors, and clinical presentation.

I. Definition and Classification

Hypertensive crises are characterized by acute, severe elevations in blood pressure that necessitate careful differentiation into hypertensive emergencies, which involve acute target-organ damage, versus hypertensive urgencies, where such damage is absent. This distinction is crucial for guiding appropriate management strategies.

Diagnostic Thresholds and Differentiation

  • Blood Pressure Criteria: Generally defined by a systolic blood pressure (SBP) ≥180 mmHg and/or a diastolic blood pressure (DBP) ≥120 mmHg.
  • Hypertensive Emergency: Diagnosed when severe hypertension is accompanied by evidence of new or worsening target-organ injury. Examples include:
    • Hypertensive encephalopathy (headache, confusion, seizures)
    • Acute ischemic or hemorrhagic stroke
    • Acute myocardial infarction or unstable angina
    • Acute left ventricular dysfunction with pulmonary edema
    • Aortic dissection
    • Acute kidney injury
    • Severe preeclampsia/eclampsia or HELLP syndrome
    • Grade III/IV hypertensive retinopathy (hemorrhages, exudates, papilledema)
  • Hypertensive Urgency: Characterized by severe BP elevation without signs or symptoms of acute end-organ damage. Patients may have headache, shortness of breath, or anxiety, but no acute organ dysfunction.
Key Point: End-Organ Damage is Definitive

The critical determinant for classifying a hypertensive crisis as an emergency is the presence of acute or progressive target-organ damage, not the absolute blood pressure value itself. Prompt identification of organ injury is paramount for immediate and appropriate intervention.

II. Epidemiology and Incidence

The incidence of hypertensive crises appears to be rising, particularly in emergency department (ED) and intensive care unit (ICU) settings. This trend is likely influenced by an aging population and an increasing prevalence of comorbidities such as chronic hypertension. However, precise incidence rates can vary significantly based on geographic region and population characteristics.

Prevalence and Trends

  • ICU/ED Impact: Hypertensive crises are a significant reason for acute hospital admissions. While hypertensive urgencies are more common, emergencies constitute a critical minority that demand immediate, intensive management.
  • Temporal Increases: The absolute number of hypertensive crises is growing, mirroring the rising global prevalence of chronic hypertension.
  • Regional Disparities: Higher rates of hypertensive crises are often observed in areas with suboptimal primary care, poor blood pressure control within the community, and limited access to healthcare resources.

Morbidity and Mortality

  • Acute Outcomes: Untreated hypertensive emergencies are associated with very high short-term morbidity and mortality.
  • Long-Term Sequelae: Survivors of hypertensive emergencies remain at increased risk for long-term cardiovascular and renal complications, including recurrent stroke, progression of chronic kidney disease (CKD), and heart failure.
Clinical Pearl: Importance of Early Action

Prompt recognition and appropriate management of hypertensive emergencies significantly reduce acute mortality. However, it is crucial to emphasize that survivors still face an elevated long-term risk of vascular events and require diligent follow-up and secondary prevention strategies.

Editor’s Note: Detailed incidence data stratified by region, patient demographics, and specific target-organ injuries should be incorporated as more comprehensive epidemiological studies become available to refine risk assessment and resource allocation.

III. Pathophysiology

The pathophysiology of hypertensive emergencies involves an abrupt and severe surge in blood pressure that overwhelms the body’s normal autoregulatory mechanisms. This leads to endothelial injury, increased vascular permeability, and a vicious cycle of vasoconstriction, inflammation, and ischemia in target organs.

Breakdown of Normal Autoregulation

  • Myogenic Response: Normally, blood vessels constrict or dilate to maintain constant tissue perfusion across a range of mean arterial pressures (MAP), typically between 60–150 mmHg. In hypertensive crises, this mechanism is overwhelmed.
  • Neurohormonal Control: The renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system activity, which normally regulate BP, can become dysregulated and contribute to the BP surge.

Endothelial Dysfunction and Injury

  • Shear Stress Effects: Extreme intravascular pressure and shear stress damage the endothelium, leading to reduced nitric oxide (a vasodilator) production and increased release of endothelin-1 (a potent vasoconstrictor).
  • Inflammation and Oxidative Stress: Endothelial injury triggers an inflammatory response, with release of cytokines and increased oxidative stress, further impairing vascular function and increasing permeability.

Consequences of Autoregulatory Failure

  • Forced Hyperperfusion: In organs like the brain and kidneys, the failure of autoregulation leads to forced hyperperfusion, damaging delicate capillary beds.
  • Capillary Leak and Edema: Increased vascular permeability results in leakage of plasma and proteins into the interstitium, causing edema (e.g., cerebral edema, pulmonary edema) and further compromising tissue oxygenation.
  • Ischemia: Paradoxically, severe vasoconstriction and microvascular damage can lead to tissue ischemia despite high systemic pressures.

Pathophysiology of Hypertensive Emergency Flowchart

A flowchart illustrating the cascade of events in hypertensive emergencies, starting from an abrupt BP surge and leading to target-organ damage.

Abrupt, Severe BP Surge
Leads to
Autoregulatory Failure
Triggers / Induces
Endothelial Injury & Dysfunction (↓NO, ↑ET-1)
Inflammation & Oxidative Stress
Results in
Target-Organ Damage (Ischemia, Edema, Infarction)
Figure 1: Pathophysiological Cascade in Hypertensive Emergencies. An abrupt rise in blood pressure overwhelms autoregulatory mechanisms, leading to endothelial injury, inflammation, and ultimately, target-organ damage through processes like ischemia and edema.
Clinical Pearl: The Triad of Damage

The core mechanism of target-organ damage in hypertensive crises can be conceptualized as a triad: vascular shear stress from the pressure surge, subsequent endothelial injury with loss of integrity, and critical failure of autoregulation. This combination precipitates the cascade leading to organ dysfunction.

IV. Impact of Pre-existing Chronic Diseases

Pre-existing chronic conditions, particularly chronic hypertension, chronic kidney disease (CKD), and diabetes mellitus, significantly predispose individuals to hypertensive crises. These conditions induce long-term changes in vascular structure and function, effectively lowering the threshold at which an acute blood pressure rise can precipitate organ damage.

Chronic Hypertension

  • Vascular Remodeling: Sustained high blood pressure leads to arterial wall thickening, increased stiffness, and reduced compliance. This makes vessels less able to accommodate sudden pressure changes.
  • Shifted Autoregulatory Curve: In chronically hypertensive individuals, the autoregulatory curve (the range of pressures over which blood flow is maintained) shifts to higher pressures. A sudden BP drop, even to “normal” levels, might cause hypoperfusion, while a surge more readily exceeds the upper limit.

Chronic Kidney Disease (CKD)

  • Volume Overload and Arterial Stiffness: CKD often involves impaired sodium and water excretion, leading to volume overload. It is also associated with increased arterial stiffness, both contributing to higher baseline pressures and reduced vascular resilience.
  • Impaired Nitric Oxide Bioavailability: Reduced nitric oxide production or increased degradation in CKD impairs endothelial-dependent vasodilation, favoring vasoconstriction.

Diabetes Mellitus

  • Endothelial Glycation and Microvascular Dysfunction: Hyperglycemia promotes advanced glycation end-product (AGE) formation, which damages endothelial cells and contributes to microvascular dysfunction, making small vessels more susceptible to injury.
  • Enhanced Oxidative Stress: Diabetes is a state of increased oxidative stress, which further impairs endothelial function and promotes inflammation.
Clinical Pearl: Diminished Buffering Capacity

Comorbid vascular changes from chronic diseases like hypertension, CKD, and diabetes significantly diminish the body’s natural buffering capacity against acute blood pressure surges. This makes individuals more vulnerable, accelerating the onset and severity of organ injury during rapid BP elevations.

V. Social Determinants of Health

Social determinants of health (SDOH) play a profound role in the risk, management, and outcomes of hypertensive crises. Factors such as access to medications and healthcare, health literacy, and socioeconomic status can directly influence an individual’s ability to control their blood pressure and their likelihood of experiencing a crisis.

Medication Access and Adherence

  • Barriers to Access: “Pharmacy deserts” (areas with limited pharmacy access), medication costs, and lack of adequate health insurance can prevent patients from obtaining necessary antihypertensive drugs.
  • Adherence Challenges: Even with access, adherence can be poor due to complex regimens, side effects, or insufficient understanding of the importance of continuous therapy. Abrupt withdrawal of certain medications, like beta-blockers or clonidine, can precipitate rebound hypertension.

Health Literacy

  • Understanding Hypertension: Limited health literacy can impair a patient’s understanding of hypertension as a chronic, often asymptomatic condition requiring lifelong management.
  • Self-Monitoring and Symptom Recognition: Difficulty in using home BP monitors or recognizing warning symptoms of worsening hypertension can delay seeking care.

Socioeconomic Factors

  • Disparities in Care: Lower socioeconomic status is often linked to reduced access to preventive care, specialist consultations, and consistent outpatient follow-up, leading to poorer BP control.
  • Environmental Stressors: Chronic stress related to socioeconomic conditions can also contribute to elevated blood pressure.
Key Point: Equity in Prevention

Addressing social determinants of health is not merely an adjunct but an essential component of strategies aimed at the equitable prevention and control of hypertensive crises. Interventions must consider these broader societal factors to be truly effective across diverse populations.

VI. Risk Factors and Precipitants

A variety of factors can precipitate a hypertensive crisis. These range from non-adherence to prescribed antihypertensive medications to underlying secondary causes of hypertension, the use of sympathomimetic substances, and acute systemic illnesses that disrupt blood pressure homeostasis.

Medication Non-Adherence or Withdrawal

  • Common Culprit: This is one of the most frequent precipitants. Reasons include cost, side effects, complex regimens, or lack of understanding.
  • Rebound Hypertension: Abrupt cessation of certain antihypertensive agents, notably centrally acting alpha-2 agonists (e.g., clonidine) and beta-blockers, can lead to a rapid and dangerous rise in blood pressure.
  • Follow-up Issues: Poor outpatient follow-up and inadequate medication reconciliation during transitions of care can contribute to non-adherence.

Secondary Hypertension

  • Underlying Conditions: Unrecognized or poorly managed secondary causes of hypertension can lead to severe BP elevations. Key examples include:
    • Renovascular disease: Renal artery stenosis can activate the RAAS, leading to severe hypertension.
    • Pheochromocytoma/Paraganglioma: These catecholamine-secreting tumors can cause episodic or sustained severe hypertension.
    • Primary aldosteronism, Cushing’s syndrome, thyroid disorders.

Illicit Drugs, Medications, and Acute Illnesses

  • Sympathomimetic Substances: Cocaine, amphetamines (including methamphetamine and MDMA/ecstasy), and some over-the-counter decongestants (e.g., pseudoephedrine) can cause sympathetic overdrive and acute, severe hypertension.
  • Other Medications: NSAIDs, corticosteroids, oral contraceptives, and certain immunosuppressants (e.g., cyclosporine) can elevate blood pressure.
  • Acute Systemic Illnesses: Conditions like eclampsia/preeclampsia, acute glomerulonephritis, sepsis, severe burns, or major trauma can trigger endothelial activation and systemic vasoconstriction, leading to hypertensive crises.
Clinical Pearl: Systematic Search for Causes

When a patient presents with a hypertensive crisis, a systematic approach to identifying potential reversible causes and precipitants is crucial. This not only guides acute management but also informs long-term strategies for prevention and optimal blood pressure control.

VII. Clinical Presentation

The clinical presentation of a hypertensive crisis is dictated by the presence and type of acute target-organ damage. While patients with hypertensive urgency may have non-specific symptoms like headache or anxiety, those with hypertensive emergencies will exhibit signs and symptoms specific to the organ system(s) affected. Recognizing these manifestations is key to determining the urgency and intensity of treatment.

Neurologic Manifestations

  • Hypertensive Encephalopathy: Characterized by severe headache, nausea, vomiting, confusion, visual disturbances, seizures, and potentially coma. These symptoms arise from cerebral hyperperfusion and edema.
  • Acute Stroke:
    • Ischemic Stroke: Focal neurological deficits (e.g., hemiparesis, aphasia, facial droop) related to a specific vascular territory.
    • Intracerebral Hemorrhage: Often presents with sudden onset of severe headache, vomiting, altered consciousness, and focal deficits that may progress rapidly.
    • Subarachnoid Hemorrhage: Typically a “thunderclap” headache, nuchal rigidity, photophobia, and altered mental status.

Cardiovascular Manifestations

  • Acute Coronary Syndrome (ACS): Chest pain or discomfort (pressure, tightness, squeezing), dyspnea, diaphoresis, nausea. ECG changes (ST elevation/depression, T-wave inversions) and elevated cardiac biomarkers confirm myocardial ischemia or infarction.
  • Acute Heart Failure / Pulmonary Edema: Severe dyspnea (often orthopnea or paroxysmal nocturnal dyspnea), cough (sometimes with frothy, pink sputum), tachypnea, tachycardia, and crackles/rales on lung auscultation. Jugular venous distension and peripheral edema may be present.
  • Aortic Dissection: Sudden onset of severe, tearing or ripping chest pain, often radiating to the back or abdomen. May be associated with pulse deficits, blood pressure differentials between limbs, syncope, or neurological symptoms if carotid arteries are involved.

Renal and Ophthalmologic Manifestations

  • Acute Kidney Injury (AKI): Often asymptomatic initially, but may present with oliguria or anuria. Diagnosed by a rise in serum creatinine and/or decrease in urine output. Urinalysis may show proteinuria, hematuria, or red blood cell casts.
  • Hypertensive Retinopathy (Grade III/IV):
    • Grade III: Retinal hemorrhages (flame-shaped or dot-blot), cotton wool spots (soft exudates indicating nerve fiber layer infarcts).
    • Grade IV: All features of Grade III plus papilledema (optic disc swelling), indicating significantly increased intracranial pressure. Patients may report blurred vision or visual field defects.
Key Point: Organ Dysfunction Dictates Urgency

The careful identification of acute end-organ injury through history, physical examination, and targeted investigations is what differentiates a hypertensive emergency from an urgency. This distinction is paramount as it dictates the necessary speed and intensity of blood pressure reduction and overall management strategy.

References

  1. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71(6):e13–e115.
  2. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.
  3. Calhoun DA, Jones D, Textor S, et al. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension. 2008;51(6):1403–1419.
  4. Anderson CS, Heeley E, Huang Y, et al; INTERACT2 Investigators. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–2365.